Teachers Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Teachers Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$3.87M	Sell	407,363 -393,601	-49%	-$3.82M	﹤0.01%	1576
2018 Q4	$7.09M	Buy	800,964 +73,921	+10%	+$713K	0.01%	1113
2018 Q3	$8.18M	Buy	727,043 +157,427	+28%	+$2.23M	0.01%	1171
2018 Q2	$7.29M	Buy	569,616 +26,381	+5%	+$386K	0.01%	1226
2018 Q1	$9.18M	Buy	543,235 +381,070	+235%	+$5.77M	0.01%	1068
2017 Q4	$1.3M	Buy	162,165 +15,143	+10%	+$122K	﹤0.01%	2102
2017 Q3	$1.14M	Buy	147,022 +426	+0.3%	+$2.7K	﹤0.01%	2156
2017 Q2	$1.08M	Buy	146,596 +59,600	+69%	+$379K	﹤0.01%	2186
2017 Q1	$648K	Buy	86,996 +3,572	+4%	+$26.2K	﹤0.01%	2402
2016 Q4	$580K	Buy	83,424 +4,025	+5%	+$27.7K	﹤0.01%	2458
2016 Q3	$653K	Buy	79,399 +9,936	+14%	+$84K	﹤0.01%	2320
2016 Q2	$563K	Buy	69,463 +3,641	+6%	+$22.9K	﹤0.01%	2351
2016 Q1	$334K	Hold	65,822	–	–	﹤0.01%	2553
2015 Q4	$508K	Hold	65,822	–	–	﹤0.01%	2401
2015 Q3	$379K	Hold	65,822	–	–	﹤0.01%	2554
2015 Q2	$604K	Buy	+65,822	New	+$735K	﹤0.01%	2420

Other funds holding IOVA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's IOVA Position: Q1 2019 in Review

Teachers Advisors reduced its Iovance Biotherapeutics (IOVA) stake by 49% in Q1 2019, selling an estimated $3.82M and leaving 407,363 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Teachers Advisors first reported a position in IOVA in Q2 2015 and has held it in 16 quarters since. The position peaked at $9.18M in Q1 2018. 153 funds tracked by Wall St. Rank hold IOVA as of Q1 2019.

Teachers Advisors held 407,363 shares of Iovance Biotherapeutics worth $3.87M as of Q1 2019.
Teachers Advisors sold 393,601 Iovance Biotherapeutics shares in Q1 2019, an estimated $3.82M.
Iovance Biotherapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1576 holding.
Teachers Advisors first reported a position in Iovance Biotherapeutics in Q2 2015 and has held it in 16 quarters since.
Teachers Advisors's Iovance Biotherapeutics position peaked at $9.18M in Q1 2018.
153 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.